Depletion of pyrimidine ribonucleotide pools is thought to be the main reason why DHODH inhibitors reduce RNA virus replication and slow down the proliferation of fast-growing cells such as activated T cells and cancer cells. This evidence concerns the gene DHODH and cancer.